Dieter Maier

Title: Dieter Maier: Innovator in Lipolytic Enzymes

Introduction

Dieter Maier is a prominent inventor based in Martinsried, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of novel enzymes. With a total of 5 patents, his work has implications for both industrial processes and medical diagnostics.

Latest Patents

Dieter Maier's latest patents include groundbreaking inventions related to lipases and phospholipases. The first patent focuses on a newly identified polynucleotide sequence that encodes a novel lipolytic enzyme. This invention features the full-length nucleotide sequence of the gene, the cDNA sequence, and the amino acid sequence of the functional protein. It also outlines methods for using these enzymes in industrial applications and diagnosing fungal infections. Additionally, the invention includes genetically modified cells that enhance the activity and expression levels of the lipolytic enzyme.

The second patent pertains to a novel phospholipase, also derived from a newly identified polynucleotide sequence. Similar to the first, this invention includes the full-length nucleotide and cDNA sequences, as well as the amino acid sequence of the functional protein. It also describes methods for utilizing these enzymes in various industrial processes and for diagnosing fungal infections, along with transformed cells that are genetically modified to adjust the enzyme's activity and expression levels.

Career Highlights

Dieter Maier is associated with Dsm IP Assets B.V., where he continues to innovate in the field of enzyme technology. His work has not only advanced scientific understanding but has also paved the way for practical applications in various industries.

Collaborations

Dieter collaborates with notable colleagues such as Christian Wagner and Fabio Spreafico. Their combined expertise contributes to the success of their projects and enhances the impact of their innovations.

Conclusion

Dieter Maier is a key figure in the development of novel lipolytic enzymes, with a focus on practical applications in industry and medicine. His contributions through patents and collaborations highlight the importance of innovation in biotechnology.